On-Q-ity develops non-invasive diagnostic monitoring tools for use in the treatment of individual cancer patients.
Industries BiotechnologyHealth DiagnosticsMedicalDiversity Spotlight (US Headquarters Only) Women FoundedHeadquarters Regions Greater Boston Area, East Coast, New England Closed Date Apr 2013 Founded Date 2004 Founders Mara Aspinall Operating Status Closed Last Funding Type Series B
Company Type For Profit
Contact Email info@on-q-ity.com Phone Number 781-895-8100
On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival.
Products
currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.